instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Prinzmetal angina'? | Rare case of coronary spastic angina during treatment of invasive group A streptococcal sepsis.
The underlying mechanisms of coronary spastic angina (CSA) is not well understood. It is unclear if an infection can trigger coronary vasospasm; the co-occurrence of sepsis and CSA has rarely been reported. We describe the c... | Recovered | ReactionOutcome | CC BY-NC | 34426432 | 19,930,419 | 2021-08-23 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Jejunal closed-loop obstruction without prior abdominal surgery during COVID-19 ICU admittance: A case report.
and importance: Closed-loop obstruction is a specific case of small bowel obstruction in which two sites of the bowel obstruct at one adjacent location. This can result in strangulation with high mortality. Th... | CEFTRIAXONE, DEXAMETHASONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC-ND | 34426766 | 20,224,681 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial flutter'. | The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients.
By July 2021, the United States had over 34.4 million confirmed COVID-19 cases. Various cardiovascular manifestations of COVID-19 have been reported including ST-elevation myocardial infarction (STEMI), and there is concern that SARS-CoV-2 may b... | ASPIRIN, ATORVASTATIN, METOPROLOL, TICAGRELOR | DrugsGivenReaction | CC BY | 34426772 | 19,985,858 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients.
By July 2021, the United States had over 34.4 million confirmed COVID-19 cases. Various cardiovascular manifestations of COVID-19 have been reported including ST-elevation myocardial infarction (STEMI), and there is concern that SARS-CoV-2 may b... | ASPIRIN, ATORVASTATIN, METOPROLOL, TICAGRELOR | DrugsGivenReaction | CC BY | 34426772 | 19,985,858 | 2021 |
What was the dosage of drug 'AZITHROMYCIN ANHYDROUS'? | The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients.
By July 2021, the United States had over 34.4 million confirmed COVID-19 cases. Various cardiovascular manifestations of COVID-19 have been reported including ST-elevation myocardial infarction (STEMI), and there is concern that SARS-CoV-2 may b... | UNK (5 DAY COURSE) | DrugDosageText | CC BY | 34426772 | 20,004,059 | 2021 |
What was the dosage of drug 'HYDROXYCHLOROQUINE'? | The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients.
By July 2021, the United States had over 34.4 million confirmed COVID-19 cases. Various cardiovascular manifestations of COVID-19 have been reported including ST-elevation myocardial infarction (STEMI), and there is concern that SARS-CoV-2 may b... | UNK (9 DAY COURSE) | DrugDosageText | CC BY | 34426772 | 20,004,059 | 2021 |
What was the dosage of drug 'LOPINAVIR\RITONAVIR'? | The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients.
By July 2021, the United States had over 34.4 million confirmed COVID-19 cases. Various cardiovascular manifestations of COVID-19 have been reported including ST-elevation myocardial infarction (STEMI), and there is concern that SARS-CoV-2 may b... | UNK (A 5-DAY COURSE) | DrugDosageText | CC BY | 34426772 | 20,004,059 | 2021 |
What was the dosage of drug 'TOCILIZUMAB'? | The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients.
By July 2021, the United States had over 34.4 million confirmed COVID-19 cases. Various cardiovascular manifestations of COVID-19 have been reported including ST-elevation myocardial infarction (STEMI), and there is concern that SARS-CoV-2 may b... | UNK (ONE DOSE) | DrugDosageText | CC BY | 34426772 | 20,004,059 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.
Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to U... | ECULIZUMAB, MYCOPHENOLATE SODIUM, PREDNISONE, TOZINAMERAN | DrugsGivenReaction | CC BY-NC-ND | 34426798 | 20,485,868 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.
Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to U... | ECULIZUMAB, MYCOPHENOLATE SODIUM, PREDNISONE, TOZINAMERAN | DrugsGivenReaction | CC BY-NC-ND | 34426798 | 20,442,311 | 2021 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.
Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to U... | 1440 MILLIGRAM, EVERY 1 DAY | DrugDosageText | CC BY-NC-ND | 34426798 | 20,469,471 | 2021 |
What was the outcome of reaction 'Decreased immune responsiveness'? | Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.
Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to U... | Recovered | ReactionOutcome | CC BY-NC-ND | 34426798 | 20,457,912 | 2021 |
What was the outcome of reaction 'Lymphopenia'? | Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.
Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to U... | Recovered | ReactionOutcome | CC BY-NC-ND | 34426798 | 20,442,311 | 2021 |
What was the outcome of reaction 'Vaccination failure'? | Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.
Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to U... | Recovered | ReactionOutcome | CC BY-NC-ND | 34426798 | 20,452,457 | 2021 |
What was the outcome of reaction 'Vaccine induced antibody absent'? | Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab.
Vaccination can prevent infection and disease due to SARS-CoV-2. Early reports indicate that immune suppressed or immune compromised populations have reduced immune responses to U... | Recovered | ReactionOutcome | CC BY-NC-ND | 34426798 | 20,457,912 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Don't close the book on tocilizumab for the treatment of severe COVID-19 pneumonia-the jury is still out: The Kuwait experience.
This cross-sectional observational study aims to report preliminary data from the first experience using tocilizumab for patients with severe acute respiratory syndrome coronavirus-2 (SARS-Co... | HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34428204 | 19,812,926 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Don't close the book on tocilizumab for the treatment of severe COVID-19 pneumonia-the jury is still out: The Kuwait experience.
This cross-sectional observational study aims to report preliminary data from the first experience using tocilizumab for patients with severe acute respiratory syndrome coronavirus-2 (SARS-Co... | HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34428204 | 19,812,926 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intestinal perforation'. | Don't close the book on tocilizumab for the treatment of severe COVID-19 pneumonia-the jury is still out: The Kuwait experience.
This cross-sectional observational study aims to report preliminary data from the first experience using tocilizumab for patients with severe acute respiratory syndrome coronavirus-2 (SARS-Co... | HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34428204 | 19,812,926 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Don't close the book on tocilizumab for the treatment of severe COVID-19 pneumonia-the jury is still out: The Kuwait experience.
This cross-sectional observational study aims to report preliminary data from the first experience using tocilizumab for patients with severe acute respiratory syndrome coronavirus-2 (SARS-Co... | HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, TOCILIZUMAB | DrugsGivenReaction | CC BY | 34428204 | 19,812,926 | 2021 |
What was the administration route of drug 'TOCILIZUMAB'? | Don't close the book on tocilizumab for the treatment of severe COVID-19 pneumonia-the jury is still out: The Kuwait experience.
This cross-sectional observational study aims to report preliminary data from the first experience using tocilizumab for patients with severe acute respiratory syndrome coronavirus-2 (SARS-Co... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34428204 | 19,812,926 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Akinesia'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arteriosclerosis coronary artery'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coronary artery stenosis'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram ST segment elevation'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram T wave biphasic'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram T wave inversion'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemodynamic instability'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular dysfunction'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34429107 | 20,660,315 | 2021-08-24 |
What was the outcome of reaction 'Akinesia'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovering | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
What was the outcome of reaction 'Arteriosclerosis coronary artery'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovering | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
What was the outcome of reaction 'Coronary artery stenosis'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovering | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovered | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
What was the outcome of reaction 'Electrocardiogram ST segment elevation'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovering | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
What was the outcome of reaction 'Electrocardiogram T wave biphasic'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovering | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
What was the outcome of reaction 'Electrocardiogram T wave inversion'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovered | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
What was the outcome of reaction 'Haemodynamic instability'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovered | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
What was the outcome of reaction 'Left ventricular dysfunction'? | Emergency cardiac imaging for coronavirus disease 2019 (COVID-19) in practice: a case of takotsubo stress cardiomyopathy.
BACKGROUND
Cardiovascular complications of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV2) are known to be associated with poor outcome. A small number of case series and report... | Recovering | ReactionOutcome | CC BY | 34429107 | 20,595,450 | 2021-08-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | CX-024414, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,809,261 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disorientation'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | CX-024414, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,809,261 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | AZTREONAM, CX-024414, INFLUENZA VIRUS VACCINE, LEVOFLOXACIN, RITUXIMAB, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotension'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | CX-024414, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,809,261 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphatic disorder'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | AZTREONAM, CX-024414, INFLUENZA VIRUS VACCINE, LEVOFLOXACIN, RITUXIMAB, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | CX-024414, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,809,261 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | AZTREONAM, CX-024414, INFLUENZA VIRUS VACCINE, LEVOFLOXACIN, RITUXIMAB, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | CX-024414, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,809,261 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | CX-024414, RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 34429981 | 19,809,261 | 2021-08 |
What was the administration route of drug 'RITUXIMAB'? | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
What was the dosage of drug 'INFLUENZA VIRUS VACCINE'? | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | 2 DOSES RECEIVED ON 23/SEP/2014 AND 20/OCT/2016 | DrugDosageText | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
What was the outcome of reaction 'Chills'? | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
What was the outcome of reaction 'Febrile neutropenia'? | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
What was the outcome of reaction 'Feeling cold'? | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
What was the outcome of reaction 'Lymphatic disorder'? | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
What was the outcome of reaction 'Neutropenia'? | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
What was the outcome of reaction 'Pancytopenia'? | Rituximab-induced acute lympholysis and pancytopenia after COVID-19 vaccination.
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have bee... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429981 | 19,793,195 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | ALBUTEROL, AMLODIPINE BESYLATE, EPLERENONE, GABAPENTIN, LOSARTAN, METFORMIN HYDROCHLORIDE, NADOLOL | DrugsGivenReaction | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | ALBUTEROL, AMLODIPINE BESYLATE, EPLERENONE, GABAPENTIN, LOSARTAN, METFORMIN HYDROCHLORIDE, NADOLOL | DrugsGivenReaction | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | ALBUTEROL, AMLODIPINE BESYLATE, EPLERENONE, GABAPENTIN, LOSARTAN, METFORMIN HYDROCHLORIDE, NADOLOL | DrugsGivenReaction | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypocalcaemia'. | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | ALBUTEROL, AMLODIPINE BESYLATE, EPLERENONE, GABAPENTIN, LOSARTAN, METFORMIN HYDROCHLORIDE, NADOLOL | DrugsGivenReaction | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypokalaemia'. | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | ALBUTEROL, AMLODIPINE BESYLATE, EPLERENONE, GABAPENTIN, LOSARTAN, METFORMIN HYDROCHLORIDE, NADOLOL | DrugsGivenReaction | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypomagnesaemia'. | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | ALBUTEROL, AMLODIPINE BESYLATE, EPLERENONE, GABAPENTIN, LOSARTAN, METFORMIN HYDROCHLORIDE, NADOLOL | DrugsGivenReaction | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypophosphataemia'. | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | ALBUTEROL, AMLODIPINE BESYLATE, EPLERENONE, GABAPENTIN, LOSARTAN, METFORMIN HYDROCHLORIDE, NADOLOL | DrugsGivenReaction | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
What was the outcome of reaction 'Diarrhoea'? | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
What was the outcome of reaction 'Fatigue'? | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
What was the outcome of reaction 'Hypocalcaemia'? | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
What was the outcome of reaction 'Hypokalaemia'? | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
What was the outcome of reaction 'Hypomagnesaemia'? | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
What was the outcome of reaction 'Hypophosphataemia'? | An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.
Metformin is known for gastrointestinal side effects, but has rarely been associated with diarrhea severe enough to cause symptomatic electrolyte abnormalities and hospitaliza... | Recovered | ReactionOutcome | CC BY-NC-ND | 34429999 | 19,796,635 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine.
Raynaud's phenomenon is a rare side effect of CGRP monoclonal antibodies. These molecular treatments are a relatively new class of drugs for the prevention of migraine. It is likely that we will see this side effect more often in the future.... | AMITRIPTYLINE, PROPRANOLOL HYDROCHLORIDE, TOPIRAMATE, VENLAFAXINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 34430000 | 19,948,963 | 2021-08 |
What was the administration route of drug 'AMITRIPTYLINE'? | Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine.
Raynaud's phenomenon is a rare side effect of CGRP monoclonal antibodies. These molecular treatments are a relatively new class of drugs for the prevention of migraine. It is likely that we will see this side effect more often in the future.... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34430000 | 19,948,963 | 2021-08 |
What was the administration route of drug 'PROPRANOLOL HYDROCHLORIDE'? | Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine.
Raynaud's phenomenon is a rare side effect of CGRP monoclonal antibodies. These molecular treatments are a relatively new class of drugs for the prevention of migraine. It is likely that we will see this side effect more often in the future.... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34430000 | 19,948,963 | 2021-08 |
What was the administration route of drug 'TOPIRAMATE'? | Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine.
Raynaud's phenomenon is a rare side effect of CGRP monoclonal antibodies. These molecular treatments are a relatively new class of drugs for the prevention of migraine. It is likely that we will see this side effect more often in the future.... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34430000 | 19,948,963 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bradycardia'. | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | AZATHIOPRINE, HYDROCORTISONE, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34430027 | 20,213,918 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bundle branch block right'. | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | AZATHIOPRINE, CEFTRIAXONE, HYDROCORTISONE, HYDROXYCHLOROQUINE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34430027 | 20,338,697 | 2021-08 |
What was the administration route of drug 'AZATHIOPRINE'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Oral | DrugAdministrationRoute | CC BY | 34430027 | 20,338,697 | 2021-08 |
What was the administration route of drug 'CEFTRIAXONE'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34430027 | 20,338,697 | 2021-08 |
What was the administration route of drug 'HYDROCORTISONE SODIUM SUCCINATE'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34430027 | 20,200,483 | 2021-08 |
What was the administration route of drug 'HYDROCORTISONE'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34430027 | 20,338,697 | 2021-08 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Oral | DrugAdministrationRoute | CC BY | 34430027 | 20,338,697 | 2021-08 |
What was the administration route of drug 'SODIUM CHLORIDE'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34430027 | 20,338,697 | 2021-08 |
What was the dosage of drug 'SODIUM CHLORIDE'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | UNK, FOUR PINTS | DrugDosageText | CC BY | 34430027 | 20,338,697 | 2021-08 |
What was the outcome of reaction 'Bradycardia'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Recovered | ReactionOutcome | CC BY | 34430027 | 20,213,918 | 2021-08 |
What was the outcome of reaction 'Bundle branch block right'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Recovered | ReactionOutcome | CC BY | 34430027 | 20,338,697 | 2021-08 |
What was the outcome of reaction 'Sinus bradycardia'? | An uncommon side effect of a very commonly used medication: A case report on hydrocortisone-induced bradycardia.
Sinus bradycardia is a rare but important side effect of high-dose hydrocortisone. It is a self-limiting condition that recovered spontaneously upon stopping the medication and did not recur with other types... | Recovered | ReactionOutcome | CC BY | 34430027 | 20,338,697 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | INFLIXIMAB, MESALAMINE | DrugsGivenReaction | CC BY | 34430172 | 19,808,915 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatocellular carcinoma'. | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | INFLIXIMAB, MESALAMINE | DrugsGivenReaction | CC BY | 34430172 | 19,808,915 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | INFLIXIMAB, MESALAMINE | DrugsGivenReaction | CC BY | 34430172 | 19,808,915 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | INFLIXIMAB, MESALAMINE | DrugsGivenReaction | CC BY | 34430172 | 19,808,915 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | INFLIXIMAB, MESALAMINE | DrugsGivenReaction | CC BY | 34430172 | 19,808,915 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | INFLIXIMAB, MESALAMINE | DrugsGivenReaction | CC BY | 34430172 | 19,808,915 | 2021-07 |
What was the dosage of drug 'INFLIXIMAB'? | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | 10 MG/KG, EVERY 8 WEEKS | DrugDosageText | CC BY | 34430172 | 19,808,915 | 2021-07 |
What was the dosage of drug 'MESALAMINE'? | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | 3 G, DAILY | DrugDosageText | CC BY | 34430172 | 19,808,915 | 2021-07 |
What was the outcome of reaction 'Hepatocellular carcinoma'? | Hepatocellular Carcinoma in a Patient With Crohn's Disease.
A 44-year-old woman with a 26-year history of Crohn's disease (CD) presented with intermittent fever, vomiting, and watery diarrhea. Her medication included an elemental diet, mesalazine, and infliximab. Liver profile and viral hepatitis markers were normal. C... | Recovered | ReactionOutcome | CC BY | 34430172 | 19,808,915 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug titration error'. | Clozapine Intoxication in a Patient on Chronic Use With a Short-Term Noncompliance.
Clozapine has been associated with various adverse effects at both subtherapeutic and standard doses. These adverse effects are most commonly seen during the initiation of therapy in treatment-naïve patients. However, reports of intoxic... | ACETAMINOPHEN, CLOZAPINE, HALOPERIDOL | DrugsGivenReaction | CC BY | 34430174 | 19,792,886 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysarthria'. | Clozapine Intoxication in a Patient on Chronic Use With a Short-Term Noncompliance.
Clozapine has been associated with various adverse effects at both subtherapeutic and standard doses. These adverse effects are most commonly seen during the initiation of therapy in treatment-naïve patients. However, reports of intoxic... | ACETAMINOPHEN, CLOZAPINE, HALOPERIDOL | DrugsGivenReaction | CC BY | 34430174 | 19,792,886 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental status changes'. | Clozapine Intoxication in a Patient on Chronic Use With a Short-Term Noncompliance.
Clozapine has been associated with various adverse effects at both subtherapeutic and standard doses. These adverse effects are most commonly seen during the initiation of therapy in treatment-naïve patients. However, reports of intoxic... | ACETAMINOPHEN, CLOZAPINE, HALOPERIDOL | DrugsGivenReaction | CC BY | 34430174 | 19,792,886 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | Clozapine Intoxication in a Patient on Chronic Use With a Short-Term Noncompliance.
Clozapine has been associated with various adverse effects at both subtherapeutic and standard doses. These adverse effects are most commonly seen during the initiation of therapy in treatment-naïve patients. However, reports of intoxic... | ACETAMINOPHEN, CLOZAPINE, HALOPERIDOL | DrugsGivenReaction | CC BY | 34430174 | 19,792,886 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment noncompliance'. | Clozapine Intoxication in a Patient on Chronic Use With a Short-Term Noncompliance.
Clozapine has been associated with various adverse effects at both subtherapeutic and standard doses. These adverse effects are most commonly seen during the initiation of therapy in treatment-naïve patients. However, reports of intoxic... | ACETAMINOPHEN, CLOZAPINE, HALOPERIDOL | DrugsGivenReaction | CC BY | 34430174 | 19,792,886 | 2021-07 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.